08:00AM - 09:00AM | Breakfast Symposium Session Sponsor Glenmark | |||
Moderators:Ajoy Biswas(Kolkata) |
08:00AM - 08:18AMTejas Shah(Mumbai)RECORD Registry: Insights from the Indian Hypertension registry |
08:20AM - 08:38AMAnil Virmani(Jamshedpur)Harnessing gluco-metabolic benefits of Sitagliptin based triple fixed dose combinations in evolving landscape of type 2 diabetes management |
08:40AM - 08:58AMJayant Panda(Cuttack)Targeting Diabesity with Biosimilar Liraglutide |
|
Kaushik Munshi(Kolkata) |
01:00PM - 01:50PM | Bariatric Surgery, Nutrition and Diabetes Management | |||
Chairpersons:Sujoy Majumdar(Kolkata) |
01:00PM - 01:20PMSubodh Banzal(Indore)Long term management of a person with T2DM post bariatric surgery |
01:20PM - 01:40PMMala Dharmalingam(Bengaluru)Nutritional supplements in T2DM does it matter? |
01:40PM - 01:50PMPanel Discussion |
|
Arindam Naskar(Kolkata) |
01:50PM - 02:40PM | Controversies in Diabetes Session Sponsor Glenmark | |||
Chairpersons:Shalini Jaggi(New Delhi) |
01:50PM - 02:10PMRajeev Chawla(New Delhi)Pre pregnancy planning in T2 DM |
02:10PM - 02:30PMSunil Gupta(Nagpur)Non insulin therapy of hyperglycaemia in pregnancy |
02:30PM - 02:40PMPanel Discussion |
|
Mary D`cruz(Kolkata) |
02:40PM - 03:30PM | Debate 01: Best Gliptin Session Sponsor MSD & Boehringer Ingelheim | |||
Chairpersons:K. K. Gangopadhyay(Kolkata) |
02:40PM - 03:00PMH. N. Chakravarti(Kolkata)Best Gliptin Sitagliptin |
03:00PM - 03:20PMSunetra Mondal(Kolkata)Best Gliptin Linagliptin |
03:20PM - 03:30PMPanel Discussion |
|
Sanjay Shrivastava(Jamshedpur) |
03:30PM - 04:20PM | Mental Health & Diabetes Session Sponsor Alteus | |||
Chairpersons:Biswajit Ghosh Dastidar(Kolkata) |
03:30PM - 03:50PMA. H. Zargar(Srinagar)Recognising depression in diabetes |
03:50PM - 04:10PMArpandev Bhattacharyya(Bengaluru)Managing diabetes in patients with dementia |
04:10PM - 04:20PMPanel Discussion |
|
Sanjay Garg(Kolkata) |
04:20PM - 05:10PM | Kidney Health & Diabetes | |||
Chairpersons:Arup Ratan Dutta(Kolkata) |
04:20PM - 04:40PMSuresh Damodaran(Coimbatore)Preventing DKD beyond RAASB and SGLT2i |
04:40PM - 05:00PMUpal Sengupta(Kolkata)Non diabetic kidney disease in T2DM |
05:00PM - 05:10PMPanel Discussion |
|
Kaushik Saha(Kolkata) |
05:10PM - 06:10PM | Industry Symposium : USV | |||
Chairpersons:Debasis Maji(Kolkata) |
05:10PM - 05:25PMBanshi Saboo(Ahmedabad)Modern SU + Metformin: Sustainable Kingpins of OADs |
05:25PM - 05:40PMJ. J. Mukherjee(Kolkata)SGLT2i as a First Line Antihyperglycemic Agent in T2DM in the Indian Context |
05:40PM - 05:55PMBrij Mohan(Kanpur)Insulin Aspart: India's Journey Towards Biosimilar Excellence |
|
Samir Dasgupta(Kolkata) |
||||
05:55PM - 06:10PMPanel Discussion |
06:10PM - 07:10PM | Industry Symposium : Torrent | |||
Chairpersons:Sanjay Chatterjee(Kolkata) |
06:10PM - 06:25PMAmitabh Sur(Kolkata)Met/SGLT2i/ DPP4i in the Indian context |
06:25PM - 06:40PMAnirban Majumder(Kolkata)Tackling PP glucose with OHA beyond SU |
06:40PM - 06:55PMIpsita Mishra(Cuttack)Positioning Imeglimin in current T2DM management |
|
Bijay Patni(Kolkata) |
||||
06:55PM - 07:10PMPanel Discussion |
07:10PM - 08:10PM | Industry Symposium : Sanofi | |||
Chairpersons:Alok Kanungo(Bhubaneswar) |
07:10PM - 07:25PMSubir Ray(Kolkata)Patient centric approach with basal insulin |
07:25PM - 07:40PMSachin Mittal(Chandigarh)Combining efficacy with simplicity for T2D management |
07:40PM - 07:55PMJothydev Kesavadev(Thiruvananthapuram)Paradigm shift in T2DM management with combination injectable of iGlarLixi |
|
Ghanshyam Goyal(Kolkata) |
||||
07:55PM - 08:10PMPanel Discussion |
08:10PM - 09:10PM | Industry Symposium : Boehringer Ingelheim | |||
Chairpersons:Sekhar Chakroborty(Siliguri) |
08:10PM - 08:30PMA. G. Unnikrishnan(Pune)Positioning SGLT2i+ DPP4i in T2DM management |
08:30PM - 08:50PMRajasekara Chakravarthi(Hyderabad)Renal-Metabolic Risk Reduction in T2DM |
08:50PM - 09:10PMPanel Discussion |
|
J. J. Mukherjee(Kolkata) |
01:00PM - 01:50PM | Session 1 | |||
Chairpersons:Masood Batin(Kolkata) |
01:00PM - 01:20PMSwyamsidha Mangaraj(Bhubaneshwar)Elevated serum triglycerides-to treat or not to treat-what is the evidence? |
01:20PM - 01:40PMPartha Pratim Chakraborty(Kolkata)What is the LDLC target in different risk groups? How best to achieve that target? |
01:40PM - 01:50PMPanel Discussion |
|
J. B. Kanwar(Bhubaneshwar) |
01:50PM - 02:40PM | Session 2 | |||
Chairpersons:Anirban Majumder(Kolkata) |
01:50PM - 02:10PMJ. B. Kanwar(Bhubaneshwar)Approach to a 22-yr-old female presenting with tetany and a corrected serum calcium value of 4.8 mg/dL |
02:10PM - 02:30PMPradip Mukherjee(Kolkata)Approach to a 22-yr-old ambulatory hypertensive male with a corrected serum calcium value of 13.5 mg/dL |
02:30PM - 02:40PMPanel Discussion |
|
Santosh Kumar Singh(Patna) |
02:40PM - 03:30PM | Session 3 | |||
Chairpersons:Debasis Maji(Kolkata) |
02:40PM - 03:00PMBinayak Sinha(Kolkata)Approach to a 24-year-old female (BMI 28) with hirsutism (periods regular/no galactorrhea) |
03:00PM - 03:20PMBelinda George(Bengaluru)Approach to a 28-year-old female (BMI 28) with irregular periods and a 9 AM follicular phase 17-OHP of 300 ng/dL |
03:20PM - 03:30PMPanel Discussion |
|
V. Sri Nagesh(Hyderabad) |
03:30PM - 04:20PM | Session 4 | |||
Chairpersons:Ghanshyam Goyal(Kolkata) |
03:30PM - 03:50PMSantosh Kumar Singh(Patna)What to assess and how to initiate THYROXINE replacement therapy in a 65-yr-old with FT4 0.2 ng/dL and TSH 128 uIU/mL |
03:50PM - 04:10PMNilanjan Sengupta(Kolkata)Should we use T3+T4 in the management of primary hypothyroidism? An evidence based deliberation |
04:10PM - 04:20PMPanel Discussion |
|
R. K. Saraogi(Kolkata) |
04:20PM - 05:10PM | Session 5 | |||
Chairpersons:Subir Ray(Kolkata) |
04:20PM - 04:40PMV. Sri Nagesh(Hyderabad)USG of a thyroid nodule: what's expected in a complete report? How to interpret it? |
04:40PM - 05:00PMKaushik Pandit(Kolkata)FNAC of a thyroid nodule: what's expected in a complete report? How to interpret it? |
05:00PM - 05:10PMPanel Discussion |
|
Salil Pal(Kolkata) |